Literature DB >> 26366817

Barriers and Misperceptions Limiting Widespread Use of Intrauterine Contraception Among Canadian Women.

Brian Hauck1, Dustin Costescu2.   

Abstract

Unintended pregnancy is a major social and public health problem with adverse effects on neonatal and developmental outcomes, as well as maternal health and wellbeing. Traditionally, family planning policies have focused on increasing contraceptive uptake in non-users; however, rates of non-use are low in many developed nations. A high proportion of unintended pregnancies are attributable to contraceptive failure, particularly when using barrier and short-acting hormonal contraceptives. Intrauterine contraceptive devices (IUCDs) are highly effective and have been shown to reduce unintended pregnancy rates. Despite this, global utilization rates are low, and IUCD uptake in Canada has been particularly low. In this review we explore why IUCDs are not more widely used, and specifically focus on barriers and misperceptions that may influence IUCD uptake, particularly in Canada. We reviewed relevant articles published in English between 1990 and 2014, through searches of PubMed and Medline, including primary studies of any design containing information on the knowledge and attitudes of health care providers and women. Providing education to care providers, women, and policy makers may help overcome misperceptions about the use of IUCDs, and may facilitate greater use. Increased support from federal and provincial health programs may also encourage the use of IUCDs in Canadian women, and help to reduce unintended pregnancy rates.

Entities:  

Keywords:  contraception; intrauterine device; intrauterine system; long-acting reversible contraception; unintended pregnancy

Mesh:

Year:  2015        PMID: 26366817     DOI: 10.1016/S1701-2163(15)30198-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  6 in total

Review 1.  Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-11-01

2.  Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care.

Authors:  Heidi S Melbostad; Gary J Badger; Catalina N Rey; Lauren K MacAfee; Anne K Dougherty; Stacey C Sigmon; Sarah H Heil
Journal:  Subst Use Misuse       Date:  2020-10-05       Impact factor: 2.164

Review 3.  Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling.

Authors:  Dustin J Costescu
Journal:  Int J Womens Health       Date:  2016-10-13

4.  Acceptability and factors associated with post-partum IUCD use among women who gave birth at bale zone health facilities, Southeast-Ethiopia.

Authors:  Alemayehu Gonie; Chanyalew Worku; Tesfaye Assefa; Daniel Bogale; Alemu Girma
Journal:  Contracept Reprod Med       Date:  2018-11-06

5.  Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.

Authors:  Paola Bianchi; Sun-Wei Guo; Marwan Habiba; Giuseppe Benagiano
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

6.  Predictors of non-use of intrauterine contraception among women aged 18-49 years in a general practice setting in the UK.

Authors:  Susan H Walker; Victoria L Newton; Lesley Hoggart; Mike J Parker
Journal:  Open Access J Contracept       Date:  2016-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.